Inhibition of type A monoamine oxidase by 1-methyl-4-phenylpyridine.
1-Methyl-4-phenylpyridine (MPP+) is now confirmed to be one of the oxidative products of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by type B monoamine oxidase (MAO-B) and is considered to cause a parkinsonism-like syndrome. We studied the effect of MPP+ on type A monoamine oxidase (MAO-A) activity in mitochondria prepared from various sources. By kinetic analysis, MPP+ was found to inhibit MAO-A in competition with the substrate, kynuramine. The Ki value of MAO-A with MPP+ in human brain synaptosomal mitochondria (1.3 microM) was much lower than the Ki values of MAO-A in other organs. Among the MAO-A samples, MAO-A in intrasynaptosomal mitochondria from human brain was the most sensitive to MPP+. The Ki value of MAO-A with MPP+ in striatum (1.6 microM and 2.0 microM for MAO-A prepared from putamen and from caudate) was similar to the Ki value of MAO-A in synaptosomes from cortex. The difference in the Ki values of MPP+ for MAO-A from various sources was considered to be due to the difference in lipid components of mitochondria. The possible significance of the inhibition of MAO-A was discussed in terms of the etiology of parkinsonism.